Source: Annual Congress 2009 - Epidemiology and management of lung cancer



Rating:

Share or cite this content

Citations should be made in the following way:
A. Rich, L. Tata, C. Free, M. Peake, P. Beckett, R. Stanley, D. Baldwin, R. Hubbard (Nottingham, Leicester, Burton-on-Trent, Leeds, United Kingdom). Lung cancer survival in the UK: are the results from the national lung cancer audit (LUCADA) dependent on completeness of case reporting?. Eur Respir J 2009; 34: Suppl. 53, 4687

Member's Comments

No comment yet.

Related content which might interest you: Treatment and survival in patients with pulmonary carcinoid tumours; an updated analysis from the UK national lung cancer audit Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features Year: 2015 Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations Source: Eur Respir J 2011; 39: 9-28 Year: 2012 Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations Source: Eur Respir J 2012; 39: 9-28 Year: 2012 Clinical management of lung cancer in France: a national survey Source: Eur Respir J 2001; 18: Suppl. 33, 228s Year: 2001 Chemotherapy for lung cancer in Scotland: a national survey Source: Eur Respir J 2002; 20: Suppl. 38, 465s Year: 2002 Lung cancer in England: Trends in survival over the duration of the national lung cancer audit Source: Annual Congress 2013 –Epidemiology of respiratory disease Year: 2013 Gender and survival in lung cancer (LC): results of a healthcare study in WestGermany Source: Eur Respir J 2001; 18: Suppl. 33, 229s Year: 2001 Improving survival for NSCLC patients in the national lung cancer audit Source: International Congress 2015 – Quality management in lung cancer Year: 2015 External comparison of hospitals concerning quality of oncological care of patients with lung cancer in an outcome evaluation study from a population-based regional cancer registry Source: Eur Respir J 2001; 18: Suppl. 33, 438s Year: 2001 Muldisciplinary conference (MDC), oncological program (OP) and practice guidelines (GL): The experience of the lung cancer (LC) clinic of a cancer hospital Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours Year: 2014 Case-mix adjusted outcomes in the national lung cancer audit in England Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009 Is there equitable access to PET-CT for lung cancer patients across a large UK cancer network; a retrospective study of 4597 patients Source: International Congress 2015 – Quality management in lung cancer Year: 2015 Does bronchial location of lung cancer influence overall survival? Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe Source: Eur Respir J, 52 (6) 1800610; 10.1183/13993003.00610-2018 Year: 2018 ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe Source: Guideline 2018 Year: 2018 ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe Source: International Congress 2018 – State of the art session: Thoracic oncology Year: 2018 EUELC project: a multi-centre, multipurpose study to investigate early stage NSCLC, and to establish a biobank for ongoing collaboration Source: Eur Respir J 2009; 34: 1477-1486 Year: 2009 Enrolment in clinical trials enhances the survival benefit provided to lung cancer patients Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016 TNM and survival in small cell lung cancer: results of a population-based study Source: Eur Respir J 2001; 18: Suppl. 33, 394s Year: 2001 Prospective population-based study on the survival of patients with lung cancer Source: Eur Respir J 2002; 19: 1087-1092 Year: 2002